Seqens competitors & alternatives

Seqens Group is a leading global player in the pharmaceutical CDMO industry, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and specialty ingredients. As companies navigate the complexities of drug development, they often look for reliable partners to manage chemical synthesis and regulatory compliance. Consequently, industry professionals frequently compare Seqens Group against other major CDMOs and specialty chemical manufacturers to evaluate capabilities in scale, technical expertise, and supply chain security. Understanding these alternatives is essential for procurement teams and R&D leaders aiming to optimize their manufacturing partnerships and ensure high-quality, compliant production throughout the drug lifecycle.

Top Seqens competitors

Seqens competitors include Lonza, Catalent, Thermo Fisher Scientific, Evonik Industries and Cambrex.

12 Alternatives

Lonza

Global CDMO ProviderEnterprise

Lonza competes with Seqens Group in providing end-to-end pharmaceutical manufacturing and custom synthesis. While Seqens Group focuses on specialized small molecule integration, Lonza offers a broader portfolio including biologics and cell therapy. Buyers often choose Lonza for its massive global infrastructure and capacity for large-scale commercial production projects.

Catalent

Drug Development PartnerEnterprise

Catalent competes with Seqens Group in the drug development and manufacturing space. Unlike Seqens Group, which emphasizes its deep expertise in complex chemical synthesis and proprietary ingredients, Catalent differentiates itself through advanced drug delivery technologies and clinical supply services, making it a preferred choice for complex formulation and packaging needs.

Thermo Fisher Scientific

Integrated CDMO ServicesEnterprise

Thermo Fisher Scientific competes with Seqens Group by offering comprehensive contract development and manufacturing services. Unlike the more specialized chemical focus of Seqens Group, Thermo Fisher provides a vast, integrated ecosystem of analytical instruments and laboratory services, which appeals to organizations seeking a single-vendor solution for their entire R&D pipeline.

Evonik Industries

Specialty Chemicals ManufacturerEnterprise

Evonik competes with Seqens Group in the supply of high-value pharmaceutical ingredients and specialty chemicals. While Seqens Group maintains a tighter focus on CDMO services for pharma, Evonik leverages its massive chemical engineering background to provide specialized lipids and polymers, offering a distinct advantage for companies requiring advanced material science integration.

Cambrex

Small Molecule CDMOEnterprise

Cambrex competes with Seqens Group in the small molecule drug substance market. Both firms prioritize chemical synthesis, but Cambrex differentiates itself through a highly focused, agile approach to small-to-mid-sized pharmaceutical projects. Buyers often compare these alternatives when seeking specific expertise in API development and rapid scale-up for clinical trials.

Unlock Full Company Details and Decision-Maker Insights

Tech stack categories related to Seqens

Explore how different tools are grouped across the tech stack based on their primary functions and use cases.

Custom Chemical Synthesis

Specialized chemical manufacturing for complex molecule development and production.

Integrated CDMO Platforms

End-to-end drug development, manufacturing, and supply chain management services.

API Development Services

Contract manufacturing of active pharmaceutical ingredients for clinical and commercial use.

Market overview

The pharmaceutical CDMO market is highly competitive, with firms differentiating based on technical specialization, global manufacturing capacity, and regulatory track records. Decision-makers must weigh the benefits of specialized chemical expertise against the convenience of large-scale, integrated service providers.

Why users choose Seqens

  • Deep expertise in complex small molecule synthesis
  • Strong focus on proprietary ingredient development
  • Reliable regulatory compliance and quality standards
  • Agile project management for mid-to-large scale production

Why users switch to alternatives

  • Need for broader biologics or cell therapy capabilities
  • Requirement for more extensive global clinical supply networks
  • Desire for a single-vendor ecosystem including lab equipment
  • Preference for different regional manufacturing footprints
  • Seeking alternative pricing models for large-scale commercialization

Discover competitor landscapes for other companies

Fung Group
Global Supply Chain ConglomerateEnterprise

Fung Group is a prominent global conglomerate with deep roots in supply chain management, retail, and distribution. As a leader in orchestrating complex global trade, the company is frequently evaluated by enterprises seeking to optimize their international logistics and sourcing operations. Because of its unique position at the intersection of retail and supply chain technology, businesses often compare Fung Group against other major conglomerates and specialized logistics providers. Understanding these competitors and alternatives is essential for stakeholders looking to benchmark operational efficiency, regional market reach, and the ability to navigate the evolving demands of global commerce and supply chain digitalization.

BDO Global
Global Accounting and AdvisoryEnterprise

BDO International Ltd is a leading global network of public accounting, tax, and advisory firms, providing professional services to a diverse range of mid-market and large-scale organizations. Known for its partner-led approach and deep industry expertise, BDO helps clients navigate complex regulatory environments and drive business growth. Because businesses often evaluate BDO against other global accounting networks and professional services firms, it is essential to compare BDO with its primary competitors. This analysis explores the top alternatives, highlighting how different firms balance global reach, specialized advisory capabilities, and service delivery models to meet the evolving needs of modern enterprises.

SEG Automotive
Automotive Component ManufacturingEnterprise

SEG Automotive North America LLC is a leading manufacturer of high-efficiency starters, generators, and 48V hybrid solutions for the automotive industry. As the automotive sector shifts toward electrification, OEMs and tier-one suppliers frequently compare SEG Automotive against other global competitors to ensure optimal powertrain performance and supply chain reliability. Whether evaluating legacy starter technology or modern mild-hybrid systems, industry professionals look for alternatives that offer superior energy efficiency, modular design, and robust manufacturing capabilities. This page provides a detailed analysis of top competitors and alternatives to help stakeholders navigate the complex landscape of automotive component manufacturing and electrification technology.

Dowlais
Automotive Engineering GroupEnterprise

Dowlais Group PLC is a specialized automotive engineering company focused on the design and manufacture of advanced driveline systems and components. As a key player in the global automotive supply chain, it provides critical hardware for both internal combustion and electric vehicles. Industry professionals often search for competitors and alternatives to Dowlais to compare engineering capabilities, supply chain reliability, and technological readiness for the transition to electric mobility. Evaluating these alternatives helps procurement teams and automotive OEMs identify the best partners for high-precision manufacturing, cost-effective production, and long-term innovation in driveline and propulsion technologies within an increasingly competitive global market.

CBRE Turkey
Commercial Real Estate ServicesEnterprise

CBRE Turkey is a leading commercial real estate services firm providing brokerage, property management, and investment advisory to institutional and corporate clients. As businesses navigate the complex Turkish property market, they often search for competitors and alternatives to ensure they are receiving the most competitive valuation, leasing, or facility management terms. Comparing CBRE Turkey against other global and local advisory firms helps stakeholders evaluate service depth, local market expertise, and fee structures. Whether you are looking for specialized valuation services or comprehensive portfolio management, understanding the landscape of alternatives is essential for making informed real estate investment decisions in the region.

SGH
Diversified Industrial ConglomerateEnterprise

Seven Group Holdings Ltd is a leading Australian diversified operating and investment group with market-leading businesses in industrial services, energy, and media. As a conglomerate, it manages complex assets including WesTrac and Coates, making it a critical player in the mining, construction, and infrastructure sectors. Professionals and investors often search for competitors and alternatives to Seven Group to benchmark performance, evaluate industrial exposure, or find specialized service providers in heavy equipment and energy infrastructure. Understanding these alternatives is essential for stakeholders looking to compare operational efficiency, asset management strategies, and market positioning within the highly competitive Australian industrial landscape.

Frequently Asked Questions About Seqens Competitors

Who are the main competitors of Seqens?
The main competitors of Seqens include Lonza, Catalent, and Thermo Fisher Scientific. Each competitor links to its company profile page.
What are some alternatives to Seqens?
Alternatives to Seqens include companies such as Thermo Fisher Scientific, Evonik Industries, and Cambrex.
Which companies compete with Seqens?
Other companies that compete with Seqens include Cambrex.